Literature DB >> 28393671

Secondary Conditions Among Males With Duchenne or Becker Muscular Dystrophy.

Rebecca Latimer1, Natalie Street2, Kristin Caspers Conway3, Kathy James4, Christopher Cunniff5, Joyce Oleszek6, Deborah Fox7, Emma Ciafaloni8, Christina Westfield7, Pangaja Paramsothy2.   

Abstract

Duchenne and Becker muscular dystrophy are X-linked neuromuscular disorders characterized by progressive muscle degeneration. Despite the involvement of multiple systems, secondary conditions among affected males have not been comprehensively described. Two hundred nine caregivers of affected males (aged 3-31 years) identified by the Muscular Dystrophy Surveillance, Tracking, and Research Network completed a mailed survey that included questions about secondary conditions impacting multiple body functions. The 5 most commonly reported conditions in males with Duchenne were cognitive deficits (38.4%), constipation (31.7%), anxiety (29.3%), depression (27.4%), and obesity (19.5%). Higher frequencies of anxiety, depression, and kidney stones were found among nonambulatory males compared to ambulatory males. Attention-deficit hyperactivity disorder (ADHD) was more common in ambulatory than nonambulatory males. These data support clinical care recommendations for monitoring of patients with Duchenne or Becker muscular dystrophy by a multidisciplinary team to prevent and treat conditions that may be secondary to the diagnosis.

Entities:  

Keywords:  Becker; Duchenne; comorbidities; muscular dystrophy; secondary conditions

Mesh:

Year:  2017        PMID: 28393671      PMCID: PMC5502756          DOI: 10.1177/0883073817701368

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  45 in total

1.  Preventing secondary conditions.

Authors:  A M Pope
Journal:  Ment Retard       Date:  1992-12

Review 2.  Prevalence of intellectual disability: a meta-analysis of population-based studies.

Authors:  Pallab K Maulik; Maya N Mascarenhas; Colin D Mathers; Tarun Dua; Shekhar Saxena
Journal:  Res Dev Disabil       Date:  2011-01-13

Review 3.  Nutrition Considerations in Duchenne Muscular Dystrophy.

Authors:  Jillian Davis; Emily Samuels; Lucille Mullins
Journal:  Nutr Clin Pract       Date:  2015-05-14       Impact factor: 3.080

Review 4.  Mental retardation in Duchenne muscular dystrophy.

Authors:  Flávia Nardes; Alexandra P Q C Araújo; Márcia Gonçalves Ribeiro
Journal:  J Pediatr (Rio J)       Date:  2012 Jan-Feb       Impact factor: 2.197

5.  The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology.

Authors:  Lisa A Miller; Paul A Romitti; Christopher Cunniff; Charlotte Druschel; Katherine D Mathews; F John Meaney; Dennis Matthews; Jiji Kantamneni; Zhen-Fang Feng; Nancy Zemblidge; Timothy M Miller; Jennifer Andrews; Deborah Fox; Emma Ciafaloni; Shree Pandya; April Montgomery; Aileen Kenneson
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-11

6.  Prevalence of fatigue, pain, and affective disorders in adults with duchenne muscular dystrophy and their associations with quality of life.

Authors:  Robert F Pangalila; Geertrudis A van den Bos; Bart Bartels; Michael Bergen; Henk J Stam; Marij E Roebroeck
Journal:  Arch Phys Med Rehabil       Date:  2015-02-27       Impact factor: 3.966

Review 7.  Duchenne muscular dystrophy.

Authors:  Michael Sussman
Journal:  J Am Acad Orthop Surg       Date:  2002 Mar-Apr       Impact factor: 3.020

Review 8.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

9.  Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations.

Authors:  Valeria Ricotti; William P L Mandy; Mariacristina Scoto; Marika Pane; Nicolas Deconinck; Sonia Messina; Eugenio Mercuri; David H Skuse; Francesco Muntoni
Journal:  Dev Med Child Neurol       Date:  2015-09-14       Impact factor: 5.449

10.  Duchenne muscular dystrophy and epilepsy.

Authors:  M Pane; S Messina; C Bruno; A D'Amico; M Villanova; B Brancalion; S Sivo; F Bianco; P Striano; D Battaglia; D Lettori; G L Vita; E Bertini; F Gualandi; V Ricotti; A Ferlini; E Mercuri
Journal:  Neuromuscul Disord       Date:  2013-03-07       Impact factor: 4.296

View more
  15 in total

1.  Autism spectrum disorders are prevalent among patients with dystrophinopathies.

Authors:  Haruo Fujino; Toshio Saito; Tsuyoshi Matsumura; Saki Shibata; Yuko Iwata; Harutoshi Fujimura; Osamu Imura
Journal:  Neurol Sci       Date:  2018-03-28       Impact factor: 3.307

Review 2.  Epileptic disorders in Becker and Duchenne muscular dystrophies: a systematic review and meta-analysis.

Authors:  Carlos Pascual-Morena; Vicente Martínez-Vizcaíno; Alicia Saz-Lara; José Francisco López-Gil; Jaime Fernández-Bravo-Rodrigo; Iván Cavero-Redondo
Journal:  J Neurol       Date:  2022-03-01       Impact factor: 4.849

3.  Occurrence of symptoms in different stages of Duchenne muscular dystrophy and their impact on social participation.

Authors:  Saskia L S Houwen-van Opstal; Lotte Heutinck; Merel Jansen; Yvonne D Krom; Edith H C Cup; Jos G M Hendriksen; Michel A A P Willemsen; Jan J G M Verschuuren; Erik H Niks; Imelda J M de Groot
Journal:  Muscle Nerve       Date:  2021-09-09       Impact factor: 3.852

4.  Descriptive Phenotype of Obsessive Compulsive Symptoms in Males With Duchenne Muscular Dystrophy.

Authors:  Angela J Lee; Edward T Buckingham; Aaron J Kauer; Katherine D Mathews
Journal:  J Child Neurol       Date:  2018-05-20       Impact factor: 1.987

Review 5.  A Review of MD STAR net's Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017.

Authors:  Kashika M Sahay; Tiffany Smith; Kristin M Conway; Paul A Romitti; Molly M Lamb; Jennifer Andrews; Shree Pandya; Joyce Oleszek; Christopher Cunniff; Rodolfo Valdez
Journal:  J Child Neurol       Date:  2018-10-22       Impact factor: 1.987

6.  Health-Related Quality of Life and Emotional Distress Among Mothers of Sons With Muscular Dystrophy as Compared to Sex- and Age Group-Matched Controls.

Authors:  Jamie L Jackson; Christina X Korth; Carine E Leslie; Jennifer Cotto; May Ling Mah; Kan Hor; Linda Cripe; Samiah Al-Zaidy; Eric M Camino; Kathleen Church; Kelly J Lehman; Victoria Shay; Jerry R Mendell
Journal:  J Child Neurol       Date:  2020-10-09       Impact factor: 1.987

7.  Labor market participation and productivity costs for female caregivers of minor male children with Duchenne and Becker muscular dystrophies.

Authors:  Rieza H Soelaeman; Michael G Smith; Kashika Sahay; J Mick Tilford; Dana Goodenough; Pangaja Paramsothy; Lijing Ouyang; Joyce Oleszek; Scott D Grosse
Journal:  Muscle Nerve       Date:  2021-10-18       Impact factor: 3.852

8.  Health Care Transition Experiences of Males with Childhood-onset Duchenne and Becker Muscular Dystrophy: Findings from the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet) Health Care Transitions and Other Life Experiences Survey.

Authors:  Pangaja Paramsothy; Adrienne R Herron; Molly M Lamb; Kathi Kinnett; Jodi Wolff; Michele L Yang; Joyce Oleszek; Shree Pandya; Annie Kennedy; Darryl Cooney; Deborah Fox; Daniel Sheehan
Journal:  PLoS Curr       Date:  2018-08-21

Review 9.  Duchenne and Becker muscular dystrophy in adolescents: current perspectives.

Authors:  Jennifer G Andrews; Richard A Wahl
Journal:  Adolesc Health Med Ther       Date:  2018-03-15

Review 10.  Dystrophin Dp116: A yet to Be Investigated Product of the Duchenne Muscular Dystrophy Gene.

Authors:  Masafumi Matsuo; Hiroyuki Awano; Masaaki Matsumoto; Masashi Nagai; Tatsuya Kawaguchi; Zhujun Zhang; Hisahide Nishio
Journal:  Genes (Basel)       Date:  2017-10-02       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.